No More Mr. NICE Guy: Pfizer/Eisai Seek Court Review Of Cost-Effectiveness Appraisal For Alzheimer’s Drugs

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".